Drug Type Small molecule drug |
Synonyms Latanoprost/TEV 90100/timolol, Latanoprost/TEV-90100/timolol, TEV-90100/latanoprost/timolol |
Target |
Action agonists, antagonists |
Mechanism PTGFR agonists(Prostanoid FP receptor agonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H24N4O3S |
InChIKeyBLJRIMJGRPQVNF-JTQLQIEISA-N |
CAS Registry26839-75-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 1 | Israel | - |